HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert D Odze Selected Research

Therapeutics

1/2018Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas.
1/2017Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.
1/2017Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.
1/2017Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD.
10/2016Role of Histologic Inflammation in the Natural History of Ulcerative Colitis.
5/2016Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.
5/2016Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.
8/2015Predictors of Disease Recurrence and Survival in Esophageal Adenocarcinomas With Complete Response to Neoadjuvant Therapy.
11/2014Liver histology during Mipomersen therapy for severe hypercholesterolemia.
7/2011Eosinophilic esophagitis: updated consensus recommendations for children and adults.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert D Odze Research Topics

Disease

36Barrett Esophagus (Barrett's Esophagus)
01/2022 - 08/2002
33Neoplasms (Cancer)
01/2022 - 02/2002
27Adenocarcinoma
09/2019 - 02/2002
14Polyps
09/2019 - 01/2002
12Aneuploidy (Aneuploid)
01/2015 - 10/2005
10Adenoma (Adenomas)
01/2018 - 01/2002
9Metaplasia
12/2021 - 11/2002
7Tetraploidy
06/2009 - 10/2005
6Inflammation (Inflammations)
10/2016 - 08/2002
6Colitis
05/2013 - 05/2004
5Carcinoma (Carcinomatosis)
01/2008 - 01/2005
4Fibrosis (Cirrhosis)
02/2017 - 11/2014
4Ulcerative Colitis
10/2016 - 08/2004
4Crohn Disease (Crohn's Disease)
05/2013 - 02/2006
3Carcinoid Tumor (Carcinoid)
01/2018 - 06/2003
3Liver Diseases (Liver Disease)
02/2017 - 05/2011
3Carcinogenesis
08/2015 - 05/2011
3Colorectal Neoplasms (Colorectal Cancer)
12/2013 - 09/2009
3Microsatellite Instability
09/2009 - 08/2007
3Colonic Neoplasms (Colon Cancer)
06/2009 - 07/2006
2Peptic Esophagitis (Reflux Esophagitis)
01/2019 - 05/2016
2Colonic Polyps
05/2011 - 01/2005
2Precancerous Conditions
06/2010 - 10/2005
2Obesity
01/2008 - 12/2007
2Pouchitis
02/2006 - 08/2004
2Neoplasm Metastasis (Metastasis)
01/2006 - 03/2005
2Abscess
05/2004 - 11/2002
2Myocarditis (Carditis)
10/2003 - 07/2003
1Burns
01/2017
1Hyperplasia
05/2016
1Esophagitis
05/2016
1Pathologic Constriction (Stenosis)
09/2015
1Edema (Dropsy)
09/2015
1Non-alcoholic Fatty Liver Disease
11/2014
1Fatty Liver
11/2014
1Hypercholesterolemia
11/2014
1Stomach Neoplasms (Stomach Cancer)
03/2014
1Disease Progression
01/2014
1Lymphocytic Colitis
02/2013
1Hypersensitivity (Allergy)
07/2011
1Tricuspid Atresia
05/2011

Drug/Important Bio-Agent (IBA)

14Biological ProductsIBA
01/2018 - 01/2002
13DNA (Deoxyribonucleic Acid)IBA
01/2018 - 10/2005
12Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2004
7MucinsIBA
01/2018 - 10/2003
6Peptides (Polypeptides)IBA
05/2011 - 05/2002
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2013 - 12/2005
5beta CateninIBA
06/2009 - 01/2005
4AcidsIBA
01/2017 - 03/2006
4Hematoxylin (Haematoxylon)IBA
07/2003 - 08/2002
4Eosine Yellowish-(YS) (Eosin)IBA
07/2003 - 08/2002
3Proton Pump InhibitorsIBA
01/2017 - 03/2005
3Keratins (Keratin)IBA
01/2014 - 01/2005
3AntigensIBA
12/2013 - 03/2005
3Pharmaceutical PreparationsIBA
01/2008 - 05/2004
3Monoclonal AntibodiesIBA
03/2005 - 02/2002
2CytokinesIBA
05/2016 - 12/2013
2Transcription Factors (Transcription Factor)IBA
08/2015 - 01/2008
2diazoluminolmelaninIBA
05/2013 - 07/2004
21-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2011 - 01/2008
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2007 - 12/2005
2alpha-methylacyl-CoA racemaseIBA
07/2006 - 03/2005
2Proteins (Proteins, Gene)FDA Link
03/2005 - 02/2002
2AntralIBA
01/2005 - 10/2003
2CollagenIBA
11/2002 - 02/2002
2Codon (Codons)IBA
05/2002 - 01/2002
1AgrinIBA
01/2022
1Bile Acids and Salts (Bile Acids)IBA
01/2019
1Hyaluronic Acid (Hyaluronan)IBA
02/2017
1AlbuminsIBA
01/2017
1Delta CateninIBA
02/2016
1CholesterolIBA
09/2015
1Serine (L-Serine)FDA Link
08/2015
1Tyrosine (L-Tyrosine)FDA Link
08/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2015
1AgarIBA
08/2015
1mipomersenIBA
11/2014
1Alanine Transaminase (SGPT)IBA
11/2014
1Keratin-17 (Keratin 17)IBA
01/2014
1Immunoglobulin G (IgG)IBA
12/2013
1Interleukin-12 (IL 12)IBA
12/2013
1neonatal Fc receptorIBA
12/2013
1MicroRNAs (MicroRNA)IBA
05/2013
1IpilimumabIBA
02/2013
1Calcibiotic Root Canal SealerIBA
09/2012
1theasinensin AIBA
09/2012
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2010
1N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
05/2010

Therapy/Procedure

12Therapeutics
01/2018 - 03/2005
5Esophagectomy
01/2019 - 01/2006
4Radiofrequency Ablation
04/2016 - 06/2009
4Colectomy
05/2010 - 07/2003
4Restorative Proctocolectomy
05/2010 - 05/2004
3Fontan Procedure (Fontan Operation)
02/2017 - 05/2011
2Surgical Instruments (Clip)
01/2022 - 12/2021
2Ablation Techniques
01/2017 - 01/2017
2Neoadjuvant Therapy
08/2015 - 01/2006
2Photochemotherapy (Photodynamic Therapy)
11/2011 - 01/2008
1Lasers (Laser)
05/2016
1Chemoprevention
08/2015